Notal Vision was founded in 2000 by Dr. Barak Azmon, M.D. and Dr. Yair Alster, M.D. Drs. Azmon and Alster, clinically trained ophthalmologists, observed how devastating vision loss can be on a patient's quality of life. Their vision was to develop better methods of detecting age-related macular degeneration (AMD) that could allow doctors to treat patients at an earlier stage and possibly prevent any loss of sight.
Drs. Azmon and Alster formed a strong team of medical and scientific professionals who developed a technology called Preferential Hyperacuity Perimetry (PHP). This technology became the foundation for the Notal Vision products.
A true pioneer in the eye care industry, Notal Vision has developed and introduced the first teleconnected home based monitoring system for AMD patients, the ForeseeHome AMD Monitoring Program.
The first generation of the PHP technology was introduced in 2004 with the launch of the Preview PHP, a device used by patients in the eye doctor’s office. Notal Vision introduced this product through distributors around the world. Carl Zeiss Meditec was the U.S. distributor for the Preview PHP. In 2006, Notal Vision terminated the distribution agreement with Carl Zeiss Meditec and launched an updated version of this office based device with a new U.S. distributor, Sightpath Medical. In 2009, Notal Vision sold this product line to Reichert Ophthalmic Instruments in order to focus on a home based telemonitoring solution. Notal Vision is no longer affiliated with the office based version of the PHP technology.
Notal Vision received FDA clearance for the ForeseeHome AMD Monitor in December 2009. In 2010, Notal Vision began a pre-launch marketing trial of the ForeseeHome AMD Monitoring Program which continues today. This revolutionary program is available to patients at risk of vision loss from AMD through a select number of eye care practices in the U.S.
Notal Vision's U.S. office and distribution center is located in St. Louis, MO, with corporate headquarters in Tel Aviv, Israel.